Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04881890 · ClinicalTrials.gov registry record · NA
Low-Carbohydrate Diabetes Prevention Program Among Veterans With Prediabetes
A NA study, sponsored by VA Ann Arbor Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT04881890: Completed NA study, sponsored by VA Ann Arbor Healthcare System.
NCT04881890 is a NA study that has completed, run by VA Ann Arbor Healthcare System. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04881890, a NA study, has completed, sponsored by VA Ann Arbor Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The investigators will conduct a single-arm mixed methods pilot study to examine the feasibility and acceptability of a low-carbohydrate diabetes prevention program (LC-DPP). The investigators will estimate weight loss as well as the percentage of participants who achieve 5% body weight loss at 6 month and 12 month timepoints. Weight loss from the pilot VA LC-DPP cohort will be compared to weight loss outcomes from previously published DPP studies and the VA MOVE! program. The investigators will also evaluate secondary outcomes including change in physical activity, mental health, psychosocial functioning, and hemoglobin A1c over the 12-month study period. The investigators will also conduct qualitative interviews with participants at 6 and 12 months.
Primary Outcome
This will be calculated by dividing by number of enrolled participants by the number of individuals invited to participate.
Interventions
- BEHAVIORAL Low-Carbohydrate Diabetes Prevention Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2021-12-22 |
| Phase | NA |
What the finished NCT04881890 record still lists
NCT04881890 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Low-Carbohydrate Diabetes Prevention Program is the first listed.
NCT04881890 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04881890 about?
NCT04881890 is a clinical study titled "Low-Carbohydrate Diabetes Prevention Program Among Veterans With Prediabetes". The investigators will conduct a single-arm mixed methods pilot study to examine the feasibility and acceptability of a low-carbohydrate diabetes prevention program (LC-DPP). The investigators will estimate weight loss as well as the percentage of participants who achieve 5% body weight loss at 6 mo...
What is the current status of trial NCT04881890?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2020-10-05. Estimated completion is 2021-12-22.
What interventions are being tested in trial NCT04881890?
The interventions under investigation include: Low-Carbohydrate Diabetes Prevention Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04881890?
This trial is sponsored by VA Ann Arbor Healthcare System, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04881890's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI